Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Cross

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Sub-Cellular Biochemistry|July 2, 2010
Development of an anti-endotoxin vaccine for sepsisAlan S Cross
Microbiology and Molecular Biology Reviews : MMBR|July 11, 2023
Hit 'em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine TargetAlan S Cross
Cytokine|July 20, 2016
IL-18/IL-1/IL-17A axis: A novel therapeutic target for neonatal sepsis?Alan S Cross
Critical Care (London, England)|December 19, 2008
What is a virulence factor?Alan S Cross
Journal of Endotoxin Research|May 25, 2002
Endotoxin tolerance-current concepts in historical perspectiveAlan S Cross
Virulence|August 27, 2013
Anti-endotoxin vaccines: back to the futureAlan S Cross
Journal of Endotoxin Research|November 8, 2007
From therapy to experimental model: a hundred years of endotoxin administration to human subjectsMarjan Bahador, Alan S Cross
Annals of Internal Medicine|March 18, 2003
A new paradigm for the treatment of sepsis: is it time to consider combination therapy?Alan S Cross, Steven M Opal
Shock (Augusta, Ga.)|December 24, 2005
The use of immunocompromised animals as models for human septic shockSteven M Opal, Alan S Cross
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2007
From rabbits to humans: the contributions of Dr. Theodore E. Woodward to tularemia researchAlan S Cross, Frank M Calia, Robert Edelman
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Sub-Cellular Biochemistry|July 2, 2010
Development of an anti-endotoxin vaccine for sepsisAlan S Cross
Microbiology and Molecular Biology Reviews : MMBR|July 11, 2023
Hit 'em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine TargetAlan S Cross
Cytokine|July 20, 2016
IL-18/IL-1/IL-17A axis: A novel therapeutic target for neonatal sepsis?Alan S Cross
Critical Care (London, England)|December 19, 2008
What is a virulence factor?Alan S Cross
Journal of Endotoxin Research|May 25, 2002
Endotoxin tolerance-current concepts in historical perspectiveAlan S Cross
Virulence|August 27, 2013
Anti-endotoxin vaccines: back to the futureAlan S Cross
Journal of Endotoxin Research|November 8, 2007
From therapy to experimental model: a hundred years of endotoxin administration to human subjectsMarjan Bahador, Alan S Cross
Annals of Internal Medicine|March 18, 2003
A new paradigm for the treatment of sepsis: is it time to consider combination therapy?Alan S Cross, Steven M Opal
Shock (Augusta, Ga.)|December 24, 2005
The use of immunocompromised animals as models for human septic shockSteven M Opal, Alan S Cross
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2007
From rabbits to humans: the contributions of Dr. Theodore E. Woodward to tularemia researchAlan S Cross, Frank M Calia, Robert Edelman
Pageof 10